NIH SBIR's Role in Working to Advance the Biotech Industry Discussed at Conference in Philadelphia

Philadelphia, PA (PressExposure) August 09, 2012 -- The National Institutes of Health will address NIH SBIR's Role in Working to Advance the Biotechnology Industry at the Biotechnology Transfer & Commercialization Conference.

Scheduled October 24-26, 2012 at the Pennsylvania Convention Center in Philadelphia, the Conference is part of the 8th Modern Drug Discovery and Development Summit.

Rob Vinson, Assistant Program Manager, SBIR/STTR Program Office, will present on behalf of the National Institutes of Health.

Bringing together the market participants who get deals done - universities, pharmaceutical companies, biotech firms, venture capital - the Conference provides a forum for open discussion and professional networking. Together they will create new technologies, new companies and new medicines.

Serving as an independent forum for discussion and commercial advancement, the Conference is a unique opportunity to hear from all market segments in an open dialogue where audience members are encouraged to participate. The program is crafted with business interests in mind, focusing on advancing promising biotechnologies from early stage research to commercial development.

For more information, please visit

About CTC

GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.

GTC (Global Technology Community), LLC, is a privately held company founded in 2002.

Press Release Source:

Press Release Submitted On: August 09, 2012 at 2:15 am
This article has been viewed 22545 time(s).